A Phase 1a/1b Study of OPT101 in Healthy Volunteers
Latest Information Update: 08 May 2024
Price :
$35 *
At a glance
- Drugs OPT 101 (Primary)
- Indications Autoimmune disorders
- Focus Adverse reactions; First in man
- Sponsors Op-T LLC
- 01 May 2024 Planned End Date changed from 1 Jun 2023 to 30 Jun 2024.
- 01 May 2024 Planned primary completion date changed from 1 Jun 2023 to 30 Jun 2024.
- 01 May 2024 Status changed from active, no longer recruiting to recruiting.